Showing results (361-370 of 427) with videos related to

Sort By:
Pageof 43
The Journal of Infectious Diseases|December 1, 2011
Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communitiesJennifer R Scott, Eugene V Millar, Marc Lipsitch, et al.
Nature Genetics|April 26, 2011
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infectionChristopher B Ford, Philana Ling Lin, Michael R Chase, et al.
Vaccine|January 13, 2024
JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak dataJennifer B Rosen, Robert J Arciuolo, Preeti Pathela, et al.
Nature Communications|January 29, 2026
Geographic spillover of antimicrobial resistance from mass distribution of azithromycinAriktha Srivathsan, Ahmed M Arzika, Ramatou Maliki, et al.
Vaccine|May 4, 2010
Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USAGili Regev-Yochay, William P Hanage, Krzysztof Trzcinski, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A Binary Prototype for Time-Series Surveillance and InterventionJason Olejarz, Till Hoffmann, Alex Zapf, et al.
Mbio|November 23, 2017
Vaccine Effects on Heterogeneity in Susceptibility and Implications for Population Health ManagementKate E Langwig, Andrew R Wargo, Darbi R Jones, et al.
Epidemics|November 16, 2025
A binary prototype for time-series surveillance and interventionJason Olejarz, Till Hoffmann, Alex Zapf, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Geographic spillover of antimicrobial resistance from mass distribution of azithromycinAriktha Srivathsan, Ahmed M Arzika, Ramatou Maliki, et al.
The New England Journal of Medicine|June 29, 2022
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of AgeChandra J Cohen-Stavi, Ori Magen, Noam Barda, et al.
Pageof 43